
Strengthening India’s Biotech Systems - The Case for Collaborative Innovation and Policy Support
In a world increasingly defined by biological risk and therapeutic urgency, India’s ambition to become to surpass $300 billion by 2030 is both timely and necessary. As the global center of gravity in life sciences shifts from scale to speed, modularity, …